Two modified forms of the SAIR model with a fuzzyfied vaccination effectiveness parameter
Sigma Journal of Engineering and Natural Sciences, cilt.43, sa.3, ss.887-898, 2025 (ESCI, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 43 Sayı: 3
- Basım Tarihi: 2025
- Doi Numarası: 10.14744/sigma.2025.00077
- Dergi Adı: Sigma Journal of Engineering and Natural Sciences
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Directory of Open Access Journals
- Sayfa Sayıları: ss.887-898
- Anahtar Kelimeler: Asymptomatic Cases, Compartmental Models, COVID-19, Fuzzy Modeling, Vaccination Effectiveness
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
In 2019, the emergence of COVID-19 underscored the critical role of mathematical modeling in understanding and forecasting global health crises. The rapid and often unnoticed spread of infectious diseases by asymptomatic carriers poses a significant challenge to public health efforts worldwide. Understanding and accurately modeling this transmission is crucial for developing effective vaccination strategies and controlling outbreaks. We address this critical issue by enhancing the SAIR model, a Susceptible-Asymptomatic-Infected-Recovered compartmental model, to better capture the dynamics of asymptomatic spread and vaccination effectiveness. This study focuses on the SAIR models to investigate the dynamics of COVID-19 transmission, with a particular emphasis on asymptomatic individuals, who can unknowingly transmit the disease. In this paper, we present two modifications to the SAIR model. The first modification assumes that individuals gain lifelong immunity after recovering from the infection. The second modification, known as the SAIRS model, considers the possibility of reinfection, meaning recovered individuals can become susceptible again. By applying these enhanced models to real-world data on daily reported COVID-19 cases in Türkiye, we aim to gain a deeper understanding of the pandemic’s behavior and progression in the country. The novelty of this work lies in the integration of a vaccine effectiveness parameter into the SAIR model, uniquely considering the delayed immunity of vaccinated individuals and the distinct transmission dynamics of both symptomatic and asymptomatic cases. Analyzing this parameter within a fuzzy environment enhances the accuracy of predictions, providing more dependable estimations of future disease scenarios. This approach offers a new dimension to epidemic modeling, contributing valuable insights to public health strategies and vaccination policies.